▶ 調査レポート

世界のオールワクチン産業2020-2026

• 英文タイトル:Global All Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが調査・発行した産業分析レポートです。世界のオールワクチン産業2020-2026 / Global All Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2020-2026 / D0MA3010927資料のイメージです。• レポートコード:D0MA3010927
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥524,300 (USD4,900)▷ お問い合わせ
  Multi User¥786,450 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,048,600 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、オールワクチンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、オールワクチンのグローバル市場動向、メーカー別競争状況、種類別市場規模(水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他)、用途別市場規模(大人用、子供用)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・オールワクチンの種類別市場2015-2026:水痘、インフルエンザ、ポリオ、A型肝炎、狂犬病、BCG、B型肝炎、百日咳、ジフテリア、破傷風、肺炎球菌、その他
・オールワクチンの用途別市場2015-2026:大人用、子供用
・オールワクチンの北米市場分析
・オールワクチンのアジア市場分析
・オールワクチンの中南米市場分析
・オールワクチンの中東・アフリカ市場分析
・関連企業情報:CNBG、ChengDa Bio、Changsheng Life、Zhifei、SINOVAC BIOTECH、NuoCheng Bio、Hualan Bio、Kangtai、SANOFI PASTEUR、Novartis、GSK
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body’s immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or “wild” pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The average price of China All Vaccine is in the increasing trend, from 2.93 USD/Dose in 2012 to 4.27 USD/Dose in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
In 2019, the global All Vaccine market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for All Vaccine.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global All Vaccine market. The analysts authoring the report have closely studied key strategies adopted by top players of the global All Vaccine market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global All Vaccine market. Readers of the report can become informed about current and future trends of the global All Vaccine market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise All Vaccine markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global All Vaccine market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global All Vaccine market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global All Vaccine market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the All Vaccine market is segmented into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Others

Market Segment by Application, the All Vaccine market is segmented into
For Adult
For Child

This report includes the following manufacturers; we can also add the other companies as you want.
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR
Novartis
GSK

The study objectives are:
To analyze and research the global All Vaccine status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key All Vaccine manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of All Vaccine are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top All Vaccine Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global All Vaccine Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Varicella
1.3.3 Influenza
1.3.4 Polio
1.3.5 Hepatitis A
1.3.6 Rabies
1.3.7 BCG
1.3.8 Hepatitis B
1.3.9 Pertussis, Diphtheria, tetanus
1.3.10 Pneumococcal
1.3.11 Others
1.4 Market Segment by Application
1.4.1 Global All Vaccine Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 For Adult
1.4.3 For Child
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global All Vaccine Revenue (2015-2026)
2.1.1 Global All Vaccine Revenue (2015-2026)
2.1.2 Global All Vaccine Sales (2015-2026)
2.2 All Vaccine Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global All Vaccine Sales by Regions (2015-2020)
2.2.2 Global All Vaccine Revenue by Regions (2015-2020)
2.3 Global Top All Vaccine Regions (Countries) Ranking by Market Size
2.4 All Vaccine Industry Trends
2.4.1 All Vaccine Market Top Trends
2.4.2 Market Drivers
2.4.3 All Vaccine Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key All Vaccine Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top All Vaccine Manufacturers by Sales (2015-2020)
3.1.1 Global All Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Global All Vaccine Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by All Vaccine Sales in 2019
3.2 Global Top Manufacturers All Vaccine by Revenue
3.2.1 Global All Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Global All Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global All Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in All Vaccine as of 2019)
3.4 Global All Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers All Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into All Vaccine Market
3.7 Key Manufacturers All Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global All Vaccine Historic Market Review by Type (2015-2020)
4.1.2 Global All Vaccine Sales Market Share by Type (2015-2020)
4.1.3 Global All Vaccine Revenue Market Share by Type (2015-2020)
4.1.4 All Vaccine Price by Type (2015-2020)
4.1 Global All Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global All Vaccine Sales Forecast by Type (2021-2026)
4.2.3 Global All Vaccine Revenue Forecast by Type (2021-2026)
4.2.4 All Vaccine Price Forecast by Type (2021-2026)

5 Global All Vaccine Market Size by Application
5.1 Global All Vaccine Historic Market Review by Application (2015-2020)
5.1.2 Global All Vaccine Sales Market Share by Application (2015-2020)
5.1.3 Global All Vaccine Revenue Market Share by Application (2015-2020)
5.1.4 All Vaccine Price by Application (2015-2020)
5.2 Global All Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global All Vaccine Sales Forecast by Application (2021-2026)
5.2.3 Global All Vaccine Revenue Forecast by Application (2021-2026)
5.2.4 All Vaccine Price Forecast by Application (2021-2026)

6 North America
6.1 North America All Vaccine Breakdown Data by Company
6.2 North America All Vaccine Breakdown Data by Type
6.3 North America All Vaccine Breakdown Data by Application
6.4 North America All Vaccine Breakdown Data by Countries
6.4.1 North America All Vaccine Sales by Countries
6.4.2 North America All Vaccine Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe All Vaccine Breakdown Data by Company
7.2 Europe All Vaccine Breakdown Data by Type
7.3 Europe All Vaccine Breakdown Data by Application
7.4 Europe All Vaccine Breakdown Data by Countries
7.4.1 Europe All Vaccine Sales by Countries
7.4.2 Europe All Vaccine Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific All Vaccine Breakdown Data by Company
8.2 Asia Pacific All Vaccine Breakdown Data by Type
8.3 Asia Pacific All Vaccine Breakdown Data by Application
8.4 Asia Pacific All Vaccine Breakdown Data by Regions
8.4.1 Asia Pacific All Vaccine Sales by Regions
8.4.2 Asia Pacific All Vaccine Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America All Vaccine Breakdown Data by Company
9.2 Latin America All Vaccine Breakdown Data by Type
9.3 Latin America All Vaccine Breakdown Data by Application
9.4 Latin America All Vaccine Breakdown Data by Countries
9.4.1 Latin America All Vaccine Sales by Countries
9.4.2 Latin America All Vaccine Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa All Vaccine Breakdown Data by Type
10.2 Middle East and Africa All Vaccine Breakdown Data by Application
10.3 Middle East and Africa All Vaccine Breakdown Data by Countries
10.3.1 Middle East and Africa All Vaccine Sales by Countries
10.3.2 Middle East and Africa All Vaccine Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 CNBG
11.1.1 CNBG Corporation Information
11.1.2 CNBG Business Overview and Total Revenue (2019 VS 2018)
11.1.3 CNBG All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 CNBG All Vaccine Products and Services
11.1.5 CNBG SWOT Analysis
11.1.6 CNBG Recent Developments
11.2 ChengDa Bio
11.2.1 ChengDa Bio Corporation Information
11.2.2 ChengDa Bio Business Overview and Total Revenue (2019 VS 2018)
11.2.3 ChengDa Bio All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 ChengDa Bio All Vaccine Products and Services
11.2.5 ChengDa Bio SWOT Analysis
11.2.6 ChengDa Bio Recent Developments
11.3 Changsheng Life
11.3.1 Changsheng Life Corporation Information
11.3.2 Changsheng Life Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Changsheng Life All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Changsheng Life All Vaccine Products and Services
11.3.5 Changsheng Life SWOT Analysis
11.3.6 Changsheng Life Recent Developments
11.4 Zhifei
11.4.1 Zhifei Corporation Information
11.4.2 Zhifei Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Zhifei All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Zhifei All Vaccine Products and Services
11.4.5 Zhifei SWOT Analysis
11.4.6 Zhifei Recent Developments
11.5 SINOVAC BIOTECH
11.5.1 SINOVAC BIOTECH Corporation Information
11.5.2 SINOVAC BIOTECH Business Overview and Total Revenue (2019 VS 2018)
11.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 SINOVAC BIOTECH All Vaccine Products and Services
11.5.5 SINOVAC BIOTECH SWOT Analysis
11.5.6 SINOVAC BIOTECH Recent Developments
11.6 NuoCheng Bio
11.6.1 NuoCheng Bio Corporation Information
11.6.2 NuoCheng Bio Business Overview and Total Revenue (2019 VS 2018)
11.6.3 NuoCheng Bio All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 NuoCheng Bio All Vaccine Products and Services
11.6.5 NuoCheng Bio SWOT Analysis
11.6.6 NuoCheng Bio Recent Developments
11.7 Hualan Bio
11.7.1 Hualan Bio Corporation Information
11.7.2 Hualan Bio Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Hualan Bio All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Hualan Bio All Vaccine Products and Services
11.7.5 Hualan Bio SWOT Analysis
11.7.6 Hualan Bio Recent Developments
11.8 Kangtai
11.8.1 Kangtai Corporation Information
11.8.2 Kangtai Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Kangtai All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Kangtai All Vaccine Products and Services
11.8.5 Kangtai SWOT Analysis
11.8.6 Kangtai Recent Developments
11.9 SANOFI PASTEUR
11.9.1 SANOFI PASTEUR Corporation Information
11.9.2 SANOFI PASTEUR Business Overview and Total Revenue (2019 VS 2018)
11.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 SANOFI PASTEUR All Vaccine Products and Services
11.9.5 SANOFI PASTEUR SWOT Analysis
11.9.6 SANOFI PASTEUR Recent Developments
11.10 Novartis
11.10.1 Novartis Corporation Information
11.10.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Novartis All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Novartis All Vaccine Products and Services
11.10.5 Novartis SWOT Analysis
11.10.6 Novartis Recent Developments
11.11 GSK
11.11.1 GSK Corporation Information
11.11.2 GSK Business Overview and Total Revenue (2019 VS 2018)
11.11.3 GSK All Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 GSK All Vaccine Products and Services
11.11.5 GSK SWOT Analysis
11.11.6 GSK Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 All Vaccine Sales Channels
12.2.2 All Vaccine Distributors
12.3 All Vaccine Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global All Vaccine Sales Forecast (2021-2026)
13.1.1 Global All Vaccine Sales Forecast by Regions (2021-2026)
13.1.2 Global All Vaccine Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America All Vaccine Sales Forecast (2021-2026)
13.2.2 North America All Vaccine Revenue Forecast (2021-2026)
13.2.3 North America All Vaccine Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe All Vaccine Sales Forecast (2021-2026)
13.3.2 Europe All Vaccine Revenue Forecast (2021-2026)
13.3.3 Europe All Vaccine Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific All Vaccine Sales Forecast (2021-2026)
13.4.2 Asia Pacific All Vaccine Revenue Forecast (2021-2026)
13.4.3 Asia Pacific All Vaccine Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America All Vaccine Sales Forecast (2021-2026)
13.5.2 Latin America All Vaccine Revenue Forecast (2021-2026)
13.5.3 Latin America All Vaccine Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa All Vaccine Sales Forecast (2021-2026)
13.6.2 Middle East and Africa All Vaccine Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa All Vaccine Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. All Vaccine Key Market Segments
Table 2. Ranking of Global Top All Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global All Vaccine Market Size Growth Rate by Type 2021-2026 (M Dose) & (Million US$)
Table 4. Major Manufacturers of Varicella
Table 5. Major Manufacturers of Influenza
Table 6. Major Manufacturers of Polio
Table 7. Major Manufacturers of Hepatitis A
Table 8. Major Manufacturers of Rabies
Table 9. Major Manufacturers of BCG
Table 10. Major Manufacturers of Hepatitis B
Table 11. Major Manufacturers of Pertussis, Diphtheria, tetanus
Table 12. Major Manufacturers of Pneumococcal
Table 13. Major Manufacturers of Others
Table 14. Global All Vaccine Market Share by Application 2019-2025 (M Dose)
Table 15. Global All Vaccine Market Size by Regions 2015-2020 (M Dose) & (Million US$)
Table 16. Global All Vaccine Sales by Regions 2015-2020 (M Dose)
Table 17. Global All Vaccine Sales Market Share by Regions 2015-2020
Table 18. Global All Vaccine Revenue by Regions 2015-2020 (Million US$)
Table 19. Global All Vaccine Revenue Market Share by Regions 2015-2020
Table 20. Top All Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 21. Market Top Trends
Table 22. All Vaccine Key Drivers: Impact Analysis (2021-2026)
Table 23. All Vaccine Key Challenges
Table 24. Main Points Interviewed from Key All Vaccine Players: Views for Future
Table 25. Global All Vaccine Sales by Manufacturers (2015-2020) (M Dose)
Table 26. Global All Vaccine Sales Share by Manufacturers (2015-2020)
Table 27. All Vaccine Revenue by Manufacturers (2015-2020) (Million US$)
Table 28. All Vaccine Revenue Share by Manufacturers (2015-2020)
Table 29. Global All Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in All Vaccine as of 2019)
Table 31. Key Manufacturers All Vaccine Average Selling Price (ASP) (2015-2020) (USD/Dose)
Table 32. Key Manufacturers All Vaccine Plants/Factories Distribution
Table 33. Key Manufacturers All Vaccine Area Served
Table 34. Date of Key Manufacturers Enter into All Vaccine Market
Table 35. Key Manufacturers All Vaccine Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Varicella Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 38. Global Influenza Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 39. Global Polio Sales ana Revenue (2015-2020) (M Dose) & (Million US$)
Table 40. Global Hepatitis A Sales ana Revenue (2015-2020) (M Dose) & (Million US$)
Table 41. Global Rabies Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 42. Global BCG Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 43. Global Hepatitis B Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 44. Global Pertussis, Diphtheria, tetanus Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 45. Global Pneumococcal Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 46. Global Others Sales and Revenue (2015-2020) (M Dose) & (Million US$)
Table 47. Global All Vaccine Sales (M Dose) by Type (2015-2020)
Table 48. Global All Vaccine Sales Share by Type (2015-2020)
Table 49. Global All Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 50. Global All Vaccine Price (M Dose) by Type (2015-2020)
Table 51. Global All Vaccine Sales (M Dose) by Type (2021-2026)
Table 52. Global All Vaccine Sales Share by Type (2021-2026)
Table 53. Global All Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 54. Global All Vaccine Revenue Share by Type (2021-2026)
Table 55. Global All Vaccine Price (M Dose) by Type (2021-2026)
Table 56. Global All Vaccine Sales (M Dose) by Application (2015-2020)
Table 57. Global All Vaccine Sales Share by Application (2015-2020)
Table 58. Global All Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 59. Global All Vaccine Price by Application 2015-2020 (USD/Dose)
Table 60. Global All Vaccine Sales by Application (2015-2020) (M Dose)
Table 61. Global All Vaccine Sales Share by Application (2015-2020)
Table 62. Global All Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 63. Global All Vaccine Revenue Share by Application (2021-2026)
Table 64. Global All Vaccine Price (M Dose) by Application (2021-2026)
Table 65. North America All Vaccine Sales by Company (2015-2020) (M Dose)
Table 66. North America All Vaccine Sales Market Share by Company (2015-2020)
Table 67. North America All Vaccine Sales by Type (2015-2020) (M Dose)
Table 68. North America All Vaccine Sales Market Share by Type (2015-2020)
Table 69. North America All Vaccine Sales by Application (2015-2020) (M Dose)
Table 70. North America All Vaccine Sales Market Share by Application (2015-2020)
Table 71. North America All Vaccine Sales by Countries (2015-2020) (M Dose)
Table 72. North America All Vaccine Sales Market Share by Countries (2015-2020)
Table 73. North America All Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 74. North America All Vaccine Revenue Market Share by Countries (2015-2020)
Table 75. Europe All Vaccine Sales by Company (2015-2020) (M Dose)
Table 76. Europe All Vaccine Sales Market Share by Company (2015-2020)
Table 77. Europe All Vaccine Sales by Type (2015-2020) (M Dose)
Table 78. Europe All Vaccine Sales Market Share by Type (2015-2020)
Table 79. Europe All Vaccine Sales by Application (2015-2020) (M Dose)
Table 80. Europe All Vaccine Sales Market Share by Application (2015-2020)
Table 81. Europe All Vaccine Sales by Countries (2015-2020) (M Dose)
Table 82. Europe All Vaccine Sales Market Share by Countries (2015-2020)
Table 83. Europe All Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 84. Europe All Vaccine Revenue Market Share by Countries (2015-2020)
Table 85. Asia Pacific All Vaccine Sales by Regions (2015-2020) (M Dose)
Table 86. Asia Pacific All Vaccine Sales Market Share by Regions (2015-2020)
Table 87. Asia Pacific All Vaccine Sales by Type (2015-2020) (M Dose)
Table 88. Asia Pacific All Vaccine Sales Market Share by Type (2015-2020)
Table 89. Asia Pacific All Vaccine Sales by Application (2015-2020) (M Dose)
Table 90. Asia Pacific All Vaccine Sales Market Share by Application (2015-2020)
Table 91. Asia Pacific All Vaccine Sales by Countries (2015-2020) (M Dose)
Table 92. Asia Pacific All Vaccine Sales Market Share by Regions (2015-2020)
Table 93. Asia Pacific All Vaccine Revenue by Regions (2015-2020) (Million US$)
Table 94. Asia Pacific All Vaccine Revenue Market Share by Regions (2015-2020)
Table 95. Latin America All Vaccine Sales by Company (2015-2020) (M Dose)
Table 96. Latin America All Vaccine Sales Market Share by Company (2015-2020)
Table 97. Latin America All Vaccine Sales by Type (2015-2020) (M Dose)
Table 98. Latin America All Vaccine Sales Market Share by Type (2015-2020)
Table 99. Latin America All Vaccine Sales by Application (2015-2020) (M Dose)
Table 100. Latin America All Vaccine Sales Market Share by Application (2015-2020)
Table 101. Latin America All Vaccine Sales by Countries (2015-2020) (M Dose)
Table 102. Latin America All Vaccine Sales Market Share by Countries (2015-2020)
Table 103. Latin America All Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 104. Latin America All Vaccine Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa All Vaccine Sales by Type (2015-2020) (M Dose)
Table 106. Middle East and Africa All Vaccine Sales Market Share by Type (2015-2020)
Table 107. Middle East and Africa All Vaccine Sales by Application (2015-2020) (M Dose)
Table 108. Middle East and Africa All Vaccine Sales Market Share by Application (2015-2020)
Table 109. Middle East and Africa All Vaccine Sales by Countries (2015-2020) (M Dose)
Table 110. Middle East and Africa All Vaccine Sales Market Share by Countries (2015-2020)
Table 111. Middle East and Africa All Vaccine Revenue by Countries (2015-2020) (Million US$)
Table 112. Middle East and Africa All Vaccine Revenue Market Share by Countries (2015-2020)
Table 113. CNBG Company Details
Table 114. CNBG Description and Business Overview
Table 115. CNBG All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. CNBG All Vaccine Sales Growth Rate (2015-2020)
Table 117. CNBG All Vaccine Sales Market Share in Global Market
Table 118. CNBG Recent Development
Table 119. ChengDa Bio Company Details
Table 120. ChengDa Bio Description and Business Overview
Table 121. ChengDa Bio All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 122. ChengDa Bio All Vaccine Sales Growth Rate (2015-2020)
Table 123. ChengDa Bio All Vaccine Sales Market Share in Global Market
Table 124. ChengDa Bio Recent Development
Table 125. Changsheng Life Company Details
Table 126. Changsheng Life Description and Business Overview
Table 127. Changsheng Life All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Changsheng Life All Vaccine Sales Growth Rate (2015-2020)
Table 129. Changsheng Life All Vaccine Sales Market Share in Global Market
Table 130. Changsheng Life Recent Development
Table 131. Zhifei Company Details
Table 132. Zhifei Description and Business Overview
Table 133. Zhifei All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 134. Zhifei All Vaccine Sales Growth Rate (2015-2020)
Table 135. Zhifei All Vaccine Sales Market Share in Global Market
Table 136. Zhifei Recent Development
Table 137. SINOVAC BIOTECH Company Details
Table 138. SINOVAC BIOTECH Description and Business Overview
Table 139. SINOVAC BIOTECH All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 140. SINOVAC BIOTECH All Vaccine Sales Growth Rate (2015-2020)
Table 141. SINOVAC BIOTECH All Vaccine Sales Market Share in Global Market
Table 142. SINOVAC BIOTECH Recent Development
Table 143. NuoCheng Bio Company Details
Table 144. NuoCheng Bio Description and Business Overview
Table 145. NuoCheng Bio All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 146. NuoCheng Bio All Vaccine Sales Growth Rate (2015-2020)
Table 147. NuoCheng Bio All Vaccine Sales Market Share in Global Market
Table 148. NuoCheng Bio Recent Development
Table 149. Hualan Bio Company Details
Table 150. Hualan Bio Description and Business Overview
Table 151. Hualan Bio All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 152. Hualan Bio All Vaccine Sales Growth Rate (2015-2020)
Table 153. Hualan Bio All Vaccine Sales Market Share in Global Market
Table 154. Hualan Bio Recent Development
Table 155. Kangtai Company Details
Table 156. Kangtai Description and Business Overview
Table 157. Kangtai All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 158. Kangtai All Vaccine Sales Growth Rate (2015-2020)
Table 159. Kangtai All Vaccine Sales Market Share in Global Market
Table 160. Kangtai Recent Development
Table 161. SANOFI PASTEUR Company Details
Table 162. SANOFI PASTEUR Description and Business Overview
Table 163. SANOFI PASTEUR All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 164. SANOFI PASTEUR All Vaccine Sales Growth Rate (2015-2020)
Table 165. SANOFI PASTEUR All Vaccine Sales Market Share in Global Market
Table 166. SANOFI PASTEUR Recent Development
Table 167. Novartis Company Details
Table 168. Novartis Description and Business Overview
Table 169. Novartis All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 170. Novartis All Vaccine Sales Growth Rate (2015-2020)
Table 171. Novartis All Vaccine Sales Market Share in Global Market
Table 172. Novartis Recent Development
Table 173. GSK Company Details
Table 174. GSK Description and Business Overview
Table 175. GSK All Vaccine Sales (M Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 176. GSK All Vaccine Sales Growth Rate (2015-2020)
Table 177. GSK All Vaccine Sales Market Share in Global Market
Table 178. GSK Recent Development
Table 179. All Vaccine Distributors List
Table 180. All Vaccine Customers List
Table 181. Global All Vaccine Sales Forecast 2021-2026 (M Dose) & (Million US$)
Table 182. Global All Vaccine Sales Forecast by Type 2021-2026 (M Dose)
Table 183. Global All Vaccine Sales Forecast by Application 2021-2026 (M Dose)
Table 184. Global All Vaccine Sales Forecast by Regions 2021-2026 (M Dose)
Table 185. Global All Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 186. North America All Vaccine Sales Forecast by Countries 2021-2026 (M Dose)
Table 187. North America All Vaccine Revenue Forecast by Countries 2021-2026
Table 188. Europe All Vaccine Sales Forecast by Countries 2021-2026 (M Dose)
Table 189. Europe All Vaccine Revenue Market Share Forecast by Countries 2021-2026
Table 190. Asia Pacific All Vaccine Sales Forecast by Regions 2021-2026 (M Dose)
Table 191. Asia Pacific All Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 192. Latin America All Vaccine Sales Forecast by Countries 2021-2026 (M Dose)
Table 193. Latin America All Vaccine Revenue Forecast by Countries 2021-2026 (Million US$)
Table 194. Middle East and Africa All Vaccine Sales Forecast by Regions 2021-2026 (M Dose)
Table 195. Middle East and Africa All Vaccine Revenue Forecast by Regions 2021-2026 (Million US$)
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. All Vaccine Product Picture
Figure 2. Global All Vaccine Sales Market Shar by Type 2015-2026
Figure 3. Varicella Figures
Figure 4. Influenza Figures
Figure 5. Polio Figures
Figure 6. Hepatitis A Figures
Figure 7. Rabies Figures
Figure 8. BCG Figures
Figure 9. Hepatitis B Figures
Figure 10. Pertussis, Diphtheria, tetanus Figures
Figure 11. Pneumococcal Figures
Figure 12. Global All Vaccine Sales Market Share by Application in 2019 & 2026
Figure 13. For Adult Use Case
Figure 14. For Child Use Case
Figure 15. All Vaccine Report Years Considered
Figure 16. Global All Vaccine Market Size 2015-2026 (Million US$)
Figure 17. Global All Vaccine Sales 2015-2020 (M Dose)
Figure 18. Global All Vaccine Market Size Market Share by Regions 2015-2020
Figure 19. Global All Vaccine Sales Market Share by Regions in 2019
Figure 20. Porter's Five Forces Analysis
Figure 21. Global All Vaccine Sales Share by Manufacturers in 2019
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by All Vaccine Sales in 2019
Figure 23. All Vaccine Value Share by Manufacturers in 2019
Figure 24. All Vaccine Revenue Share by Manufacturers In 2019
Figure 25. All Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global All Vaccine Revenue Share by Type (2015-2020)
Figure 27. Global All Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 28. Global All Vaccine Market Share by Price Range (2015-2020)
Figure 29. Global All Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global All Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. North America All Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 32. U.S. All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 33. Canada All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 34. Europe All Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. Germany All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 36. France All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 37. U.K. All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 38. Italy All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 39. Russia All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 40. Asia Pacific All Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 41. China All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 42. Japan All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 43. South Korea All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 44. India All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 45. Australia All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 46. Taiwan All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 47. Indonesia All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 48. Thailand All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 49. Malaysia All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 50. Philippines All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 51. Vietnam All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 52. Latin America All Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 53. Mexico All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 54. Brazil All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 55. Argentina All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 56. Middle East and Africa All Vaccine Revenue Growth Rate 2015-2020 (Million US$)
Figure 57. Turkey All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 58. Saudi Arabia All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 59. U.A.E All Vaccine Sales Growth Rate (2015-2020) (M Dose)
Figure 60. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. ChengDa Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Changsheng Life Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Zhifei Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. SINOVAC BIOTECH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. NuoCheng Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Kangtai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. SANOFI PASTEUR Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. All Vaccine Value Chain
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 74. North America All Vaccine Sales Growth Rate Forecast (2021-2026) (M Dose)
Figure 75. North America All Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Europe All Vaccine Sales Growth Rate Forecast (2021-2026) (M Dose)
Figure 77. Europe All Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Asia Pacific All Vaccine Sales Growth Rate Forecast (2021-2026) (M Dose)
Figure 79. Asia Pacific All Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 80. Latin America All Vaccine Sales Growth Rate Forecast (2021-2026) (M Dose)
Figure 81. Latin America All Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 82. Middle East and Africa All Vaccine Sales Growth Rate Forecast (2021-2026) (M Dose)
Figure 83. Middle East and Africa All Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed